AF
CNMD icon

Amalgamated Financial’s CONMED CNMD Stock Holding History

Amalgamated Financial’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.12M Buy
+14,270
New +$1.99M 0.02% 882

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Amalgamated Financial's CNMD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in CONMED (CNMD) in Q1 2022: 14,270 shares worth $2.12M. The stake represents 0.02% of the portfolio and ranks #882 among its holdings.

281 funds tracked by Wall St. Rank hold CNMD as of Q1 2022.

  • Amalgamated Financial held 14,270 shares of CONMED worth $2.12M as of Q1 2022.
  • CONMED was a new Amalgamated Financial position in Q1 2022.
  • CONMED made up 0.02% of Amalgamated Financial's portfolio in Q1 2022, its #882 holding.
  • 281 funds tracked by Wall St. Rank held CONMED as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.